COVID-19 Research Page
Real is Relevant
When the novel Coronavirus emerged worldwide in January 2020, scientists not only scrambled to develop tests but also to understand the biology of the disease. There was a lot they didn’t know. Scientists began tackling the problem with the tools and knowledge already on hand from studying other infectious diseases like Dengue, Zika, and Ebola. But SARS-CoV-2 proved challenging in ways current technologies were unable to address, limiting studies to extrapolations and inferences. It’s through innovation and technologies like the Creoptix® WAVEsystem that advance discovery and understanding. The drive to know more, study every angle, and make every measurement. With the ability to measure fast transitions in undiluted crude samples, all within a disposable cartridge, the WAVE makes challenging studies possible.
With no-clog and disposable sensor chips, the WAVEsystem enables the robust characterization of kinetics on both small molecules and biologics. You can work safely and avoid cross-contamination between experiments, as well as be confident about your kinetic data and accelerate your vaccine research and development.
“Understanding the dynamics of our detection reagents in complex matrices presents a big challenge when developing new assay platforms, particularly as we advance the limits of sensitivity with novel amplification technologies. The WAVEdelta system opens up new exciting opportunities for the project by giving us a real-time view of these interactions. The impressive detection range and versatility of the system will be a huge asset as the project progresses”
